Gerber Kawasaki Wealth & Investment Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $247K | Buy |
470
+9
| +2% | +$5.05K | 0.01% | 321 |
|
|
2026
Q1 | $259K | Sell |
461
-41
| -8% | -$26.3K | 0.01% | 300 |
|
|
2025
Q4 | $340K | Buy |
502
+5
| +1% | +$3.4K | 0.01% | 266 |
|
|
2025
Q3 | $318K | Buy |
497
+26
| +6% | +$15.8K | 0.01% | 265 |
|
|
2025
Q2 | $253K | Buy |
+471
| New | +$225K | 0.01% | 278 |
|
|
2024
Q4 | – | Sell |
-459
| Closed | -$232K | – | 290 |
|
|
2024
Q3 | $232K | Sell |
459
-35
| -7% | -$17K | 0.01% | 260 |
|
|
2024
Q2 | $241K | Buy |
494
+1
| +0.2% | +$502 | 0.01% | 250 |
|
|
2024
Q1 | $266K | Hold |
493
| – | – | 0.01% | 237 |
|
|
2023
Q4 | $274K | Sell |
493
-25
| -5% | -$11.7K | 0.02% | 216 |
|
|
2023
Q3 | $227K | Hold |
518
| – | – | 0.02% | 227 |
|
|
2023
Q2 | $260K | Sell |
518
-372
| -42% | -$178K | 0.02% | 218 |
|
|
2023
Q1 | $445K | Sell |
890
-12
| -1% | -$5.74K | 0.04% | 173 |
|
|
2022
Q4 | $368K | Sell |
902
-6
| -0.7% | -$2.33K | 0.03% | 178 |
|
|
2022
Q3 | $295K | Buy |
908
+14
| +2% | +$5.14K | 0.03% | 183 |
|
|
2022
Q2 | $313K | Buy |
894
+37
| +4% | +$15.1K | 0.03% | 183 |
|
|
2022
Q1 | $468K | Sell |
857
-7
| -0.8% | -$3.68K | 0.04% | 164 |
|
|
2021
Q4 | $568K | Sell |
864
-30
| -3% | -$18.8K | 0.05% | 148 |
|
|
2021
Q3 | $555K | Hold |
894
| – | – | 0.07% | 101 |
|
|
2021
Q2 | $564K | Hold |
894
| – | – | 0.06% | 138 |
|
|
2021
Q1 | $437K | Sell |
894
-1
| -0.1% | -$501 | 0.05% | 140 |
|
|
2020
Q4 | $447K | Sell |
895
-19
| -2% | -$8.5K | 0.06% | 118 |
|
|
2020
Q3 | $359K | Buy |
914
+15
| +2% | +$5.55K | 0.08% | 89 |
|
|
2020
Q2 | $296K | Buy |
899
+8
| +0.9% | +$2.32K | 0.07% | 108 |
|
|
2020
Q1 | $215K | Hold |
891
| – | – | 0.06% | 112 |
|
|
2019
Q4 | $231K | Sell |
891
-20
| -2% | -$5.27K | 0.06% | 113 |
|
|
2019
Q3 | $247K | Sell |
911
-194
| -18% | -$54K | 0.07% | 110 |
|
|
2019
Q2 | $304K | Hold |
1,105
| – | – | 0.09% | 93 |
|
|
2019
Q1 | $247K | Sell |
1,105
-20
| -2% | -$4.13K | 0.07% | 104 |
|
|
2018
Q4 | $209K | Sell |
1,125
-305
| -21% | -$62.5K | 0.07% | 104 |
|
|
2018
Q3 | $355K | Buy |
1,430
+230
| +19% | +$55.8K | 0.1% | 82 |
|
|
2018
Q2 | $265K | Hold |
1,200
| – | – | 0.08% | 88 |
|
|
2018
Q1 | $229K | Sell |
1,200
-410
| -25% | -$75.7K | 0.07% | 102 |
|
|
2017
Q4 | $251K | Sell |
1,610
-135
| -8% | -$21.3K | 0.09% | 98 |
|
|
2017
Q3 | $276K | Sell |
1,745
-240
| -12% | -$37.9K | 0.1% | 91 |
|
|
2017
Q2 | $320K | Buy |
+1,985
| New | +$322K | 0.12% | 90 |
|
Other funds holding IDXX
Gerber Kawasaki Wealth & Investment Management's IDXX Position: Q2 2026 in Review
Gerber Kawasaki Wealth & Investment Management increased its Idexx Laboratories (IDXX) stake by 2% in Q2 2026, buying an estimated $5.05K and bringing the position to 470 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #321.
Gerber Kawasaki Wealth & Investment Management first reported a position in IDXX in Q2 2017 and has held it in 35 quarters since. The position peaked at $568K in Q4 2021. 883 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Gerber Kawasaki Wealth & Investment Management held 470 shares of Idexx Laboratories worth $247K as of Q2 2026.
- Gerber Kawasaki Wealth & Investment Management bought 9 Idexx Laboratories shares in Q2 2026, an estimated $5.05K.
- Idexx Laboratories made up 0.01% of Gerber Kawasaki Wealth & Investment Management's portfolio in Q2 2026, its #321 holding.
- Gerber Kawasaki Wealth & Investment Management first reported a position in Idexx Laboratories in Q2 2017 and has held it in 35 quarters since.
- Gerber Kawasaki Wealth & Investment Management's Idexx Laboratories position peaked at $568K in Q4 2021.
- 883 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.